Stock Screener App

Frei -

Installieren

14.92

0.86% -0.13

after-market

Handel nachbörslich: 14.92

Nurix Therapeutics Inc (NRIX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Nurix Therapeutics Inc-Aktie (NRIX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-11-30	2025-08-31	2025-05-31	2025-02-28	2024-08-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	71.99% 13.58	7.894	44.06	18.45	12.59
Operating Expenses	2.63% 96.67	99.28	92.38	81.32	67.20
Benefits Costs and Expenses	2.67% 91.80	94.31	86.76	74.80	61.46
Costs And Expenses	2.67% 91.80	94.31	86.76	74.80	61.46
Depreciation and Amortization	4.54% 2.12	2.028	2.242	2.35	2.394
Operating Income/Loss	9.07% -83.09	-91.39	-48.32	-62.86	-54.61
Income/Loss From Continuing Operations Before Tax	9.49% -78.22	-86.42	-42.70	-56.35	-48.87
Income Tax Expense/Benefit	-	-	0.76	-	0.082
Income/Loss From Continuing Operations After Tax	9.49% -78.22	-86.42	-43.46	-56.35	-48.96
Net Income/Loss	9.49% -78.22	-86.42	-43.46	-56.35	-48.96
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	96.68% 2.7974	84.16	83.88	83.56	72.78
Diluted Average Shares	96.68% 2.7974	84.16	83.88	83.56	72.78
Basic Earnings Per Share	19.42% -0.83	-1.03	-0.52	-0.67	-0.67
Diluted Earnings Per Share	19.42% -0.83	-1.03	-0.52	-0.67	-0.67
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RVMD

$99.29

1.20%

ROIV

$27.80

0.00%

MRNA

$52.37

0.06%

BNTX

$89.31

0.77%

INSM

$144.00

0.91%

ONC

$282.72

0.15%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters